Emergent BioSolutions Ownership | Who Owns Emergent BioSolutions?


OverviewForecastRevenueFinancialsChartTranscripts

Emergent BioSolutions Ownership Summary


Emergent BioSolutions is owned by 59.61% institutional investors, 2.15% insiders, and 38.24% retail investors. Blackrock is the largest institutional shareholder, holding 7.36% of EBS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.02% of its assets in Emergent BioSolutions shares.

EBS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockEmergent BioSolutions59.61%2.15%38.24%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustrySpecialty & Generic Drug Manufacturers Stocks34.90%10.53%54.58%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock3.84M7.36%$26.18M
Vanguard group3.67M7.02%$25.00M
Charles schwab investment management3.17M6.07%$21.59M
Morgan stanley1.24M2.38%$8.47M
Millennium management946.30K1.81%$6.45M
Invesco896.97K1.72%$6.12M
American century companies881.89K1.69%$6.01M
Connor, clark & lunn investment management843.39K1.62%$5.75M
D. e. shaw827.80K1.59%$5.65M
Fuller & thaler asset management739.83K1.42%$5.05M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Values first advisors466.15K1.90%$3.18M
Kent lake capital300.00K0.92%$2.05M
Hilltop158.75K0.13%$1.08M
Headlands142.16K0.10%$969.50K
Point72 asia (singapore) pte.71.08K0.10%$484.75K
Whitebox advisors500.00K0.10%$3.41M
Seacrest wealth management115.00K0.09%$784.27K
Contrarian capital management40.00K0.09%$272.80K
Palisade capital management, lp453.83K0.08%$3.10M
State of wyoming45.48K0.05%$310.14K

Top Buyers

HolderShares% AssetsChange
American century companies881.89K0.00%623.20K
Whitebox advisors500.00K0.10%500.00K
D. e. shaw827.80K0.01%411.13K
Jpmorgan chase649.50K0.00%375.96K
Jane street group490.75K0.00%367.57K

Top Sellers

HolderShares% AssetsChange
Blackrock3.84M0.00%-3.22M
Avidity partners management lp---1.91M
Charles schwab investment management3.17M0.00%-985.07K
State street198.13K0.00%-859.47K
Renaissance173.75K0.00%-717.55K

New Positions

HolderShares% AssetsChangeValue
Whitebox advisors500.00K0.10%500.00K$3.41M
Kent lake capital300.00K0.92%300.00K$2.05M
Headlands142.16K0.10%142.16K$969.50K
Wellington management group llp113.99K0.00%113.99K$777.44K
Lazard asset management101.46K0.00%101.46K$691.00K

Sold Out

HolderChange
Federation des caisses desjardins du quebec-4.00
Financial gravity asset management-9.00
Nelson, van denburg & campbell wealth management group-10.00
Signaturefd-59.00
Innealta capital-60.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20241495.67%31,651,6794.07%591.78%64-21.95%5042.86%
Jun 30, 202413910.32%30,408,059-15.80%581.22%8053.85%35-22.22%
Mar 31, 2024126-9.35%36,115,932-11.70%691.08%52-14.75%45-2.17%
Dec 31, 2023139-16.27%40,903,645-0.92%791.26%61-15.28%46-16.36%
Sep 30, 2023166-12.63%41,285,195-9.70%790.98%72-8.86%55-25.68%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.64M3.02%-
SPDR® S&P Biotech ETF1.59M3.00%17.59K
Schwab Fundamental U.S. Small CompanyETF1.60M2.95%-
Avantis US Small Cap Value ETF1.52M2.80%-
Invesco FTSE RAFI US 1500 Small-Mid ETF901.64K1.70%-
Vanguard Institutional Extnd Mkt Idx Tr803.26K1.48%-12.22K
Vanguard Strategic Equity Inv582.97K1.10%-241.03K
Palisade Small Cap Core Equity420.74K0.80%137.25K
Schwab Fundamental US Small Company Idx309.85K0.59%-159.99K
Fidelity Extended Market Index307.96K0.58%-4.59K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 12, 2024DeGolyer Donald W-Sell$272.75K
Nov 11, 2024White Marvin L-Sell$171.02K
Jun 04, 2024Zoon Kathryn C-Sell$61.10K
May 29, 2024Zoon Kathryn C-Sell$8.44K
May 21, 2024Zoon Kathryn C-Sell$6.29K

Insider Transactions Trends


DateBuySell
2024 Q4-2
2024 Q3--
2024 Q2-3
2024 Q1--
2023 Q4--

EBS Ownership FAQ


Who Owns Emergent BioSolutions?

Emergent BioSolutions shareholders are primarily institutional investors at 59.61%, followed by 2.15% insiders and 38.24% retail investors. The average institutional ownership in Emergent BioSolutions's industry, Specialty & Generic Drug Manufacturers Stocks, is 34.90%, which Emergent BioSolutions exceeds.

Who owns the most shares of Emergent BioSolutions?

Emergent BioSolutions’s largest shareholders are Blackrock (3.84M shares, 7.36%), Vanguard group (3.67M shares, 7.02%), and Charles schwab investment management (3.17M shares, 6.07%). Together, they hold 20.44% of Emergent BioSolutions’s total shares outstanding.

Does Blackrock own Emergent BioSolutions?

Yes, BlackRock owns 7.36% of Emergent BioSolutions, totaling 3.84M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 26.18M$. In the last quarter, BlackRock decreased its holdings by -3.221M shares, a -45.62% change.

Who is Emergent BioSolutions’s biggest shareholder by percentage of total assets invested?

Values first advisors is Emergent BioSolutions’s biggest shareholder by percentage of total assets invested, with 1.90% of its assets in 466.15K Emergent BioSolutions shares, valued at 3.18M$.

Who is the top mutual fund holder of Emergent BioSolutions shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Emergent BioSolutions shares, with 3.02% of its total shares outstanding invested in 1.64M Emergent BioSolutions shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools